Freedom of Information on enquiry about Yellow Card report regarding infant medical overdose (FOI-20-579)
Published 24 March 2021
© Crown copyright 2021
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-18-january-2021/freedom-of-information-on-enquiry-about-yellow-card-report-regarding-infant-medical-overdose-foi-20-579
Thank you for your Freedom of Information (FOI) request dated 19th December 2020, where you requested the following information:
‘Has the MHRA been alerted to the medication overdose and circumstances and the death of the baby, either by the Chair of the investigation, anyone from the investigation team, the NMC or by Hampshire Constabulary who were also fully aware of this during their own investigation and by 2006 at the latest, or by any other norganisation or department?’
Upon review of the Yellow Card data that has been voluntarily provided to us by patients, carers, healthcare professionals and pharmaceutical companies alike, we have been unable to identify a reportnthat matches the descriptions posed within your initial email to us and therefore believe we are not in possession of this report.
To note, if you would like to this can be reported via the Yellow Card scheme, there is no time limit as to when incidents can be reported. Reporting is available via our online tool, here: https://yellowcard.mhra.gov.uk/. If you are dissatisfied with the handling of your request, you have the right to ask for an internal review.
Internal review requests should be submitted within two months of the date of this response; and can be addressed to this email address. Yours sincerely, FOI Team,
Vigilance and Risk Management of Medicines Division
The MHRA information supplied in response to your request is subject to Crown copyright. The FOIA only entitles you to access to MHRA information.
For information on the reproduction or re-use of MHRA information, please visit https://www.gov.uk/government/publications/reproduce-or-re-use-mhra-information/reproduce-or-re-use-mhrainformation
If you have a query about this email, please contact us. If you are unhappy with our decision, you may ask for it to be reviewed. That review will be undertaken by a senior member of the Agency who has not previously been involved in your request. If you wish to pursue that option please write to the Communications Directorate, Medicines and Healthcare products Regulatory Agency, (via this email address). After that, if you remain dissatisfied, you may ask the Information Commissioner at:
The Information Commissioner’s Office Wycliffe House Water Lane Wilmslow Cheshire SK9 5AF
Copyright notice
The information supplied in response to your request is the copyright of MHRA and/or a third party or parties, and has been supplied for your personal use only. You may not sell, resell or otherwise use any information provided without prior agreement from the copyright holder.